[Advances on treatment of limited-disease small cell lung cancer]
- PMID: 22008112
- PMCID: PMC5999944
- DOI: 10.3779/j.issn.1009-3419.2011.10.08
[Advances on treatment of limited-disease small cell lung cancer]
Similar articles
-
[Advances about treatment of small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):819-24. doi: 10.3779/j.issn.1009-3419.2011.10.09. Zhongguo Fei Ai Za Zhi. 2011. PMID: 22008113 Free PMC article. Review. Chinese. No abstract available.
-
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer.J Oncol Pract. 2016 Feb;12(2):111-7. doi: 10.1200/JOP.2015.009068. J Oncol Pract. 2016. PMID: 26869647 Review.
-
Recent clinical advances in lung cancer management.J Clin Oncol. 2014 Apr 1;32(10):973-82. doi: 10.1200/JCO.2013.53.1228. Epub 2014 Feb 24. J Clin Oncol. 2014. PMID: 24567433 Review.
-
Treatment of lung cancer.Radiol Clin North Am. 2012 Sep;50(5):961-74. doi: 10.1016/j.rcl.2012.06.003. Radiol Clin North Am. 2012. PMID: 22974781 Review.
-
[Combined-modality therapy for lung cancer].Nihon Rinsho. 2010 Jun;68(6):1121-8. Nihon Rinsho. 2010. PMID: 20535966 Review. Japanese.
Cited by
-
Combining serum CDK1 with tumor markers for the diagnosis of small cell lung cancer.Clin Transl Oncol. 2025 May;27(5):2005-2013. doi: 10.1007/s12094-024-03722-y. Epub 2024 Oct 13. Clin Transl Oncol. 2025. PMID: 39397200
References
-
- Sundstrom S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase Ⅲ trial with 5 years' follow-up. J Clin Oncol. 2002;20(24):4665–4672. doi: 10.1200/JCO.2002.12.111. - DOI - PubMed
-
- Caprario LC, Kent DM, Trikalinos TA, et al. Determinants of chemotherapy administration and effects of chemotherapy on survival in elderly patients with small cell lung cancer (SCLC): A SEER-medicare analysis. J Clin Oncol. 2011;29(15_S):7083 [abstract].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical